Company

MindPeak GmbH

MindPeak GmbH makes AI software for clinical pathology, covering tumor identification and biomarker quantification.

About

MindPeak develops AI diagnostic software for clinical pathology that quantifies biomarkers such as PD-L1, HER2 and Ki-67 in cancers. Its customers include hospitals, clinical laboratories and research institutions, mainly in Europe and North America. Founded in 2018 and based in Hamburg, Germany, it raised USD 15.3 mn in a Series A round on December 29, 2023, led by ZEISS Ventures and Innovationsstarter Fonds Hamburg.

2Funding rounds

5Investors

Sign in to see more

Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.

Sign in